Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy For Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy For Cancer. This report contains market size and forecasts of Gene Therapy For Cancer in global, including the following market information:
Global Gene Therapy For Cancer Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Gene Therapy For Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Rb Gene Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Gene Therapy For Cancer include GLIEAD, REGENXBIO, Autolus, American Gene Technologies, Arcellx, AUSTRIANOVA, Alphavax, Cellectis and Chimeron, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapy For Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy For Cancer Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Gene Therapy For Cancer Market Segment Percentages, by Type, 2022 (%)
Rb Gene
P53 Gene
APC Gene
NF1 Gene
Others
Global Gene Therapy For Cancer Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Gene Therapy For Cancer Market Segment Percentages, by Application, 2022 (%)
Cancer Treatment
Tissue Repair
Others
Global Gene Therapy For Cancer Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Gene Therapy For Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy For Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Therapy For Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GLIEAD
REGENXBIO
Autolus
American Gene Technologies
Arcellx
AUSTRIANOVA
Alphavax
Cellectis
Chimeron
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapy For Cancer, market overview.
Chapter 2: Global Gene Therapy For Cancer market size in revenue.
Chapter 3: Detailed analysis of Gene Therapy For Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapy For Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy For Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy For Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy For Cancer Overall Market Size
2.1 Global Gene Therapy For Cancer Market Size: 2022 VS 2035
2.2 Global Gene Therapy For Cancer Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy For Cancer Players in Global Market
3.2 Top Global Gene Therapy For Cancer Companies Ranked by Revenue
3.3 Global Gene Therapy For Cancer Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy For Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Therapy For Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy For Cancer Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy For Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy For Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy For Cancer Market Size Markets, 2022 & 2035
4.1.2 Rb Gene
4.1.3 P53 Gene
4.1.4 APC Gene
4.1.5 NF1 Gene
4.1.6 Others
4.2 By Type - Global Gene Therapy For Cancer Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy For Cancer Revenue, 2018-2023
4.2.2 By Type - Global Gene Therapy For Cancer Revenue, 2024-2035
4.2.3 By Type - Global Gene Therapy For Cancer Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy For Cancer Market Size, 2022 & 2035
5.1.2 Cancer Treatment
5.1.3 Tissue Repair
5.1.4 Others
5.2 By Application - Global Gene Therapy For Cancer Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy For Cancer Revenue, 2018-2023
5.2.2 By Application - Global Gene Therapy For Cancer Revenue, 2024-2035
5.2.3 By Application - Global Gene Therapy For Cancer Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Gene Therapy For Cancer Market Size, 2022 & 2035
6.2 By Region - Global Gene Therapy For Cancer Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy For Cancer Revenue, 2018-2023
6.2.2 By Region - Global Gene Therapy For Cancer Revenue, 2024-2035
6.2.3 By Region - Global Gene Therapy For Cancer Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Gene Therapy For Cancer Revenue, 2018-2035
6.3.2 US Gene Therapy For Cancer Market Size, 2018-2035
6.3.3 Canada Gene Therapy For Cancer Market Size, 2018-2035
6.3.4 Mexico Gene Therapy For Cancer Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Gene Therapy For Cancer Revenue, 2018-2035
6.4.2 Germany Gene Therapy For Cancer Market Size, 2018-2035
6.4.3 France Gene Therapy For Cancer Market Size, 2018-2035
6.4.4 U.K. Gene Therapy For Cancer Market Size, 2018-2035
6.4.5 Italy Gene Therapy For Cancer Market Size, 2018-2035
6.4.6 Russia Gene Therapy For Cancer Market Size, 2018-2035
6.4.7 Nordic Countries Gene Therapy For Cancer Market Size, 2018-2035
6.4.8 Benelux Gene Therapy For Cancer Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Gene Therapy For Cancer Revenue, 2018-2035
6.5.2 China Gene Therapy For Cancer Market Size, 2018-2035
6.5.3 Japan Gene Therapy For Cancer Market Size, 2018-2035
6.5.4 South Korea Gene Therapy For Cancer Market Size, 2018-2035
6.5.5 Southeast Asia Gene Therapy For Cancer Market Size, 2018-2035
6.5.6 India Gene Therapy For Cancer Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Gene Therapy For Cancer Revenue, 2018-2035
6.6.2 Brazil Gene Therapy For Cancer Market Size, 2018-2035
6.6.3 Argentina Gene Therapy For Cancer Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy For Cancer Revenue, 2018-2035
6.7.2 Turkey Gene Therapy For Cancer Market Size, 2018-2035
6.7.3 Israel Gene Therapy For Cancer Market Size, 2018-2035
6.7.4 Saudi Arabia Gene Therapy For Cancer Market Size, 2018-2035
6.7.5 UAE Gene Therapy For Cancer Market Size, 2018-2035
7 Gene Therapy For Cancer Companies Profiles
7.1 GLIEAD
7.1.1 GLIEAD Company Summary
7.1.2 GLIEAD Business Overview
7.1.3 GLIEAD Gene Therapy For Cancer Major Product Offerings
7.1.4 GLIEAD Gene Therapy For Cancer Revenue in Global Market (2018-2023)
7.1.5 GLIEAD Key News & Latest Developments
7.2 REGENXBIO
7.2.1 REGENXBIO Company Summary
7.2.2 REGENXBIO Business Overview
7.2.3 REGENXBIO Gene Therapy For Cancer Major Product Offerings
7.2.4 REGENXBIO Gene Therapy For Cancer Revenue in Global Market (2018-2023)
7.2.5 REGENXBIO Key News & Latest Developments
7.3 Autolus
7.3.1 Autolus Company Summary
7.3.2 Autolus Business Overview
7.3.3 Autolus Gene Therapy For Cancer Major Product Offerings
7.3.4 Autolus Gene Therapy For Cancer Revenue in Global Market (2018-2023)
7.3.5 Autolus Key News & Latest Developments
7.4 American Gene Technologies
7.4.1 American Gene Technologies Company Summary
7.4.2 American Gene Technologies Business Overview
7.4.3 American Gene Technologies Gene Therapy For Cancer Major Product Offerings
7.4.4 American Gene Technologies Gene Therapy For Cancer Revenue in Global Market (2018-2023)
7.4.5 American Gene Technologies Key News & Latest Developments
7.5 Arcellx
7.5.1 Arcellx Company Summary
7.5.2 Arcellx Business Overview
7.5.3 Arcellx Gene Therapy For Cancer Major Product Offerings
7.5.4 Arcellx Gene Therapy For Cancer Revenue in Global Market (2018-2023)
7.5.5 Arcellx Key News & Latest Developments
7.6 AUSTRIANOVA
7.6.1 AUSTRIANOVA Company Summary
7.6.2 AUSTRIANOVA Business Overview
7.6.3 AUSTRIANOVA Gene Therapy For Cancer Major Product Offerings
7.6.4 AUSTRIANOVA Gene Therapy For Cancer Revenue in Global Market (2018-2023)
7.6.5 AUSTRIANOVA Key News & Latest Developments
7.7 Alphavax
7.7.1 Alphavax Company Summary
7.7.2 Alphavax Business Overview
7.7.3 Alphavax Gene Therapy For Cancer Major Product Offerings
7.7.4 Alphavax Gene Therapy For Cancer Revenue in Global Market (2018-2023)
7.7.5 Alphavax Key News & Latest Developments
7.8 Cellectis
7.8.1 Cellectis Company Summary
7.8.2 Cellectis Business Overview
7.8.3 Cellectis Gene Therapy For Cancer Major Product Offerings
7.8.4 Cellectis Gene Therapy For Cancer Revenue in Global Market (2018-2023)
7.8.5 Cellectis Key News & Latest Developments
7.9 Chimeron
7.9.1 Chimeron Company Summary
7.9.2 Chimeron Business Overview
7.9.3 Chimeron Gene Therapy For Cancer Major Product Offerings
7.9.4 Chimeron Gene Therapy For Cancer Revenue in Global Market (2018-2023)
7.9.5 Chimeron Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene Therapy For Cancer Market Opportunities & Trends in Global Market
Table 2. Gene Therapy For Cancer Market Drivers in Global Market
Table 3. Gene Therapy For Cancer Market Restraints in Global Market
Table 4. Key Players of Gene Therapy For Cancer in Global Market
Table 5. Top Gene Therapy For Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Therapy For Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Therapy For Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Therapy For Cancer Product Type
Table 9. List of Global Tier 1 Gene Therapy For Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy For Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene Therapy For Cancer Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Gene Therapy For Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Therapy For Cancer Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Gene Therapy For Cancer Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Gene Therapy For Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Therapy For Cancer Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Gene Therapy For Cancer Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Gene Therapy For Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Therapy For Cancer Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Therapy For Cancer Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Therapy For Cancer Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Therapy For Cancer Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Therapy For Cancer Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Therapy For Cancer Revenue, (US$, Mn), 2024-2035
Table 30. GLIEAD Company Summary
Table 31. GLIEAD Gene Therapy For Cancer Product Offerings
Table 32. GLIEAD Gene Therapy For Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. GLIEAD Key News & Latest Developments
Table 34. REGENXBIO Company Summary
Table 35. REGENXBIO Gene Therapy For Cancer Product Offerings
Table 36. REGENXBIO Gene Therapy For Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. REGENXBIO Key News & Latest Developments
Table 38. Autolus Company Summary
Table 39. Autolus Gene Therapy For Cancer Product Offerings
Table 40. Autolus Gene Therapy For Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Autolus Key News & Latest Developments
Table 42. American Gene Technologies Company Summary
Table 43. American Gene Technologies Gene Therapy For Cancer Product Offerings
Table 44. American Gene Technologies Gene Therapy For Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. American Gene Technologies Key News & Latest Developments
Table 46. Arcellx Company Summary
Table 47. Arcellx Gene Therapy For Cancer Product Offerings
Table 48. Arcellx Gene Therapy For Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Arcellx Key News & Latest Developments
Table 50. AUSTRIANOVA Company Summary
Table 51. AUSTRIANOVA Gene Therapy For Cancer Product Offerings
Table 52. AUSTRIANOVA Gene Therapy For Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. AUSTRIANOVA Key News & Latest Developments
Table 54. Alphavax Company Summary
Table 55. Alphavax Gene Therapy For Cancer Product Offerings
Table 56. Alphavax Gene Therapy For Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Alphavax Key News & Latest Developments
Table 58. Cellectis Company Summary
Table 59. Cellectis Gene Therapy For Cancer Product Offerings
Table 60. Cellectis Gene Therapy For Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Cellectis Key News & Latest Developments
Table 62. Chimeron Company Summary
Table 63. Chimeron Gene Therapy For Cancer Product Offerings
Table 64. Chimeron Gene Therapy For Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Chimeron Key News & Latest Developments
List of Figures
Figure 1. Gene Therapy For Cancer Segment by Type in 2022
Figure 2. Gene Therapy For Cancer Segment by Application in 2022
Figure 3. Global Gene Therapy For Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Therapy For Cancer Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Gene Therapy For Cancer Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy For Cancer Revenue in 2022
Figure 8. By Type - Global Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 9. By Application - Global Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 10. By Type - Global Gene Therapy For Cancer Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 12. By Application - Global Gene Therapy For Cancer Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 14. By Region - Global Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 15. By Country - North America Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 16. US Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 20. Germany Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 21. France Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 28. China Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 32. India Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 34. Brazil Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Gene Therapy For Cancer Revenue Market Share, 2018-2035
Figure 37. Turkey Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Gene Therapy For Cancer Revenue, (US$, Mn), 2018-2035
Figure 41. GLIEAD Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. REGENXBIO Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Autolus Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. American Gene Technologies Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Arcellx Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AUSTRIANOVA Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Alphavax Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Cellectis Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Chimeron Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
